Genes like DBI are positively associated with immune-activating cells (CD8+ T cells) and negatively associated with immune-suppressive cells (Tregs and MDSCs), suggesting that they may enhance anti-tumor immunity. The gene discussed is CD8A; the disease is neoplasm.